Orthofix Medical rises on CMS reversal of non-invasive bone growth stimulators

Regulatoryapprovednon-invasive bone growth stimulatorsPositive

AI Analysis

Summary

Orthofix Medical received a favorable CMS reversal decision regarding reimbursement for non-invasive bone growth stimulators, leading to a stock price increase.

Outcome Details

CMS reversal of prior decision on non-invasive bone growth stimulators

Importance:7/10

Sentiment:

0.80

CMSregulatory approvalreimbursementbone growth stimulatorsreversalof prior decision

Related Companies

$MDCE

Read the original article

Published by Seeking Alpha Healthcare on July 2, 2026 8:58 PM

Read Original